GO:0000077 DNA damage checkpoint signaling: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000077 DNA damage checkpoint signaling is the signal transduction process that detects DNA lesions and arrests the cell cycle to allow repair.
• The checkpoint is orchestrated by sensor kinases (ATM, ATR, DNA-PK), transducer kinases (CHK1, CHK2) and effector proteins (p53, CDC25, WEE1).
• Checkpoint signaling is a major barrier against cancer, and its dysfunction drives genomic instability and tumor progression.
• DNA damage checkpoint kinases are validated targets for radiotherapy and chemotherapy sensitization.
• Checkpoint activation is coupled to immune signaling through micronuclei and pattern recognition receptors.
• CRISPR knockout, point mutation, knock-in and overexpression models are essential to dissect checkpoint gene function.
Description
DNA damage checkpoint signaling (GO:0000077) is a signal transduction process that contributes to a DNA damage checkpoint, ensuring that cells arrest the cell cycle and repair lesions before replication or mitosis. This biological process is initiated by sensor kinases that recognize DNA breaks or replication stress and is amplified through transducer kinases that phosphorylate downstream effectors, ultimately coordinating cell cycle arrest, DNA repair, senescence or apoptosis. Because checkpoint signaling is frequently altered in cancer and influences responses to genotoxic therapy, it is a central area of biomedical research. Understanding its molecular players and regulatory logic is essential for developing targeted interventions.
DNA damage checkpoint signaling At A Glance
| GO ID | GO:0000077 |
|---|---|
| GO term | DNA damage checkpoint signaling |
| Ontology | biological_process |
| Synonym | DNA damage checkpoint; DNA damage response, signal transduction resulting in cell cycle arrest; signal transduction involved in DNA damage checkpoint |
| Major function | Detects DNA lesions and arrests the cell cycle to allow repair |
| Key kinases | ATM, ATR, DNA-PK, CHK1, CHK2, WEE1 |
| Key effectors | TP53, CDC25A/C, CDKN1A (p21), MDM2 |
| Cellular outcome | Cell cycle arrest, DNA repair, senescence or apoptosis |
| Disease relevance | Cancer, neurodegeneration, premature aging |
What Is GO:0000077?
According to the Gene Ontology, DNA damage checkpoint signaling (GO:0000077) is a signal transduction process that contributes to a DNA damage checkpoint. It encompasses the sensing of DNA damage, the transmission of signals through kinase cascades, and the execution of checkpoint responses such as cell cycle arrest and repair activation.
Why Is DNA damage checkpoint signaling Important in Cell Biology?
DNA damage checkpoint signaling is critical for maintaining genomic integrity and preventing cancer. Its dysfunction leads to the accumulation of mutations and chromosomal instability, which are hallmarks of tumorigenesis. Moreover, checkpoint kinases are attractive targets for sensitizing cancer cells to radiotherapy and chemotherapy. The pathway also intersects with immune surveillance through the recognition of micronuclei, linking DNA damage to innate immune activation.
• Prevents genomic instability by arresting the cell cycle at checkpoints.
• Coordinates DNA repair with cell cycle progression.
• Frequently mutated or dysregulated in cancer.
• Determines sensitivity to radiotherapy and DNA-damaging chemotherapy.
• Mediates cellular senescence and aging phenotypes.
• Links DNA damage to innate immune signaling via micronuclei.
• Provides targets for cancer therapy (e.g., CHK1, WEE1, ATM inhibitors).
• Essential for development and tissue homeostasis.
What Happens During DNA damage checkpoint signaling?
DNA damage sensing
In simple terms: Special proteins act like sentinels that detect broken DNA.
Sensor kinases such as ATM, ATR and DNA-PK are recruited to sites of DNA damage or replication stress. ATM is activated by double-strand breaks, while ATR responds to single-stranded DNA and replication protein A (RPA)-coated lesions. These kinases initiate a phosphorylation cascade that amplifies the damage signal.
Signal transduction to effector kinases
In simple terms: The sentinels pass the alarm to messenger proteins.
ATM phosphorylates CHK2, and ATR phosphorylates CHK1. These effector kinases then phosphorylate downstream targets such as CDC25 phosphatases, WEE1 and p53, thereby transmitting the checkpoint signal. The balance between CHK1 and CHK2 activity determines the strength and duration of the arrest.
Cell cycle arrest
In simple terms: The cell presses pause on division to fix the damage.
Phosphorylation of CDC25A/C by CHK1/CHK2 leads to their degradation or inhibition, preventing activation of CDK complexes and causing arrest in G1/S or G2/M. p53 stabilization induces CDKN1A (p21), which further reinforces the G1 arrest.
DNA repair and recovery
In simple terms: While paused, the cell repairs the damage and then resumes.
Checkpoint signaling promotes DNA repair by homologous recombination or non-homologous end joining. Once repair is complete, the checkpoint is silenced through phosphatases (e.g., WIP1) and degradation of checkpoint proteins, allowing cell cycle restart.
Outcomes: senescence or apoptosis
In simple terms: If damage is too severe, the cell permanently stops dividing or self-destructs.
Persistent checkpoint activation can trigger cellular senescence or apoptosis via p53 and its targets. This prevents propagation of damaged cells and is a key tumor suppressor mechanism.
Key Genes Involved in GO:0000077 DNA damage checkpoint signaling
The following genes are core components of DNA damage checkpoint signaling, as established in the literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATM | Sensor kinase for double-strand breaks | Target for radiosensitization; mutated in ataxia-telangiectasia |
| ATR | Sensor kinase for replication stress | Target for cancer therapy; essential for replication fork stability |
| DNA-PK | Sensor kinase for non-homologous end joining | Target for radiosensitization; involved in DNA repair |
| CHEK1 | Effector kinase downstream of ATR | Target for cancer therapy; regulates cell cycle arrest |
| CHEK2 | Effector kinase downstream of ATM | Mutated in familial breast cancer; regulates p53 |
| TP53 | Transcription factor inducing cell cycle arrest and apoptosis | Most frequently mutated tumor suppressor |
| CDKN1A | p21, CDK inhibitor mediating G1 arrest | Biomarker of p53 activity |
| CDC25A | Phosphatase activating CDKs | Target of CHK1/CHK2; regulates G1/S transition |
| CDC25C | Phosphatase activating CDK1 | Target of CHK1; regulates G2/M transition |
| WEE1 | Kinase inhibiting CDK1 | Target for cancer therapy; regulates G2/M checkpoint |
| MDM2 | E3 ubiquitin ligase targeting p53 | Regulates p53 stability; target for cancer therapy |
| H2AX | Histone variant phosphorylated at damage sites | Marker of DNA damage; used in imaging |
| RAD51 | Recombinase for homologous recombination | Key for repair; target for cancer therapy |
| BRCA1 | Scaffold for DNA repair and checkpoint | Mutated in breast/ovarian cancer |
| BRCA2 | Homologous recombination mediator | Mutated in breast/ovarian cancer |
| PARP1 | Poly(ADP-ribose) polymerase for repair | Target for synthetic lethality with BRCA mutations |
| WIP1 | Phosphatase silencing checkpoint | Oncogene; regulates recovery from arrest |
How Is DNA damage checkpoint signaling Regulated?
DNA damage checkpoint signaling is tightly regulated by phosphorylation and dephosphorylation events. The WIP1 phosphatase (PPM1D) dephosphorylates ATM, CHK1 and p53, thereby terminating the checkpoint and allowing cell cycle restart. Additionally, ubiquitin-mediated degradation of CDC25A and CHK1 contributes to checkpoint silencing. Cross-talk with the DNA repair machinery ensures that the checkpoint remains active until repair is complete.
DNA damage checkpoint signaling and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATM | Ataxia-telangiectasia; cancer predisposition | ATM knockout cell lines; patient-derived iPSCs |
| TP53 | Li-Fraumeni syndrome; most cancers | TP53 knockout and point-mutant knock-in models |
| CHEK2 | Familial breast cancer | CHEK2 knockout and kinase-dead knock-in |
| BRCA1 | Hereditary breast and ovarian cancer | BRCA1 knockout; PARP inhibitor sensitivity assays |
| PPM1D | Cancer; neurodevelopmental disorders | WIP1 overexpression and knockout models |
Cancer
Defects in DNA damage checkpoint signaling lead to genomic instability and cancer predisposition. Mutations in ATM, CHEK2, TP53 and BRCA1/2 are associated with increased cancer risk. Conversely, cancer cells often rely on remaining checkpoint pathways for survival under replication stress, making checkpoint kinases attractive therapeutic targets.
Neurodegeneration
Impaired DNA damage checkpoint signaling contributes to neuronal death in neurodegenerative diseases. ATM mutations cause ataxia-telangiectasia, characterized by neurodegeneration and cancer predisposition.
Aging and senescence
Persistent checkpoint activation can induce cellular senescence, a hallmark of aging. Senescent cells accumulate with age and contribute to age-related pathologies.
Immune signaling
DNA damage checkpoint signaling is linked to innate immune activation through the recognition of micronuclei by cGAS-STING. This connection has implications for cancer immunotherapy.
From DNA damage checkpoint signaling-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ATM abolish checkpoint arrest? | ATM knockout cell line |
| Does a specific CHK2 mutation impair p53 activation? | CHK2 point-mutation knock-in |
| Can a tagged ATM be used to study recruitment kinetics? | Endogenous ATM knock-in with fluorescent tag |
| Does overexpression of WIP1 bypass checkpoint arrest? | WIP1 overexpression stable cell line |
| Which genes are essential for checkpoint recovery? | Genome-wide CRISPR knockout library screening |
| Does a cancer-associated TP53 mutation alter transcriptional output? | TP53 point-mutation knock-in |
How to Study the DNA damage checkpoint signaling Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality for checkpoint | Identify novel checkpoint regulators |
| Phosphoproteomics | Kinase substrate phosphorylation | Map signaling cascades |
| Live-cell imaging | Protein recruitment and dynamics | Study sensor activation |
| RNA-seq | Transcriptional changes | Analyze p53-dependent gene expression |
| Western blot | Protein expression and phosphorylation | Validate checkpoint activation |
| Flow cytometry | Cell cycle distribution | Measure checkpoint arrest |
| Comet assay | DNA damage levels | Assess repair efficiency |
| Immunofluorescence | Nuclear foci formation | Detect damage markers like γH2AX |
CRISPR knockout screens
Genome-wide CRISPR knockout screens can identify genes required for DNA damage checkpoint signaling. Cells are treated with DNA-damaging agents and sgRNA enrichment is measured to pinpoint essential checkpoint components.
Phosphoproteomics
Mass spectrometry-based phosphoproteomics quantifies changes in phosphorylation events after DNA damage, revealing kinase substrates and signaling dynamics.
Live-cell imaging
Fluorescently tagged checkpoint proteins (e.g., GFP-ATM, RFP-CHK1) allow real-time monitoring of recruitment to damage sites and cell cycle arrest.
Transcriptomics
RNA-seq after DNA damage identifies transcriptional programs downstream of p53 and other checkpoint effectors, providing insights into cell fate decisions.
How CRISPR Can Be Used to Study GO:0000077 DNA damage checkpoint signaling
Knockout
CRISPR knockout of checkpoint genes (e.g., ATM, ATR, CHEK1) abolishes specific checkpoint responses, allowing researchers to dissect pathway hierarchy and identify synthetic lethal interactions.
Point Mutation
Point mutations (e.g., kinase-dead CHK1 or phosphorylation-deficient CDC25A) can be introduced to study the functional significance of specific residues in checkpoint signaling.
Knock-in
Knock-in of tagged versions of checkpoint proteins (e.g., GFP-ATM) enables real-time imaging and proteomic analysis of endogenous complexes.
Overexpression
Overexpression of checkpoint inhibitors (e.g., WIP1) or constitutively active kinases can reveal sufficiency for cell cycle arrest or recovery.
How EDITGENE Supports DNA damage checkpoint signaling Research
Researchers studying DNA damage checkpoint signaling-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated with a phenotype. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for DNA damage checkpoint signaling research.
Frequently Asked Questions About DNA damage checkpoint signaling
What is DNA damage checkpoint signaling?
DNA damage checkpoint signaling (GO:0000077) is a signal transduction process that detects DNA damage and arrests the cell cycle to allow repair.
What genes are involved in DNA damage checkpoint signaling?
Key genes include ATM, ATR, CHEK1, CHEK2, TP53, CDKN1A, CDC25A/C, WEE1 and MDM2.
How does the DNA damage checkpoint work?
Sensor kinases (ATM/ATR) detect damage, activate effector kinases (CHK1/CHK2), which phosphorylate CDC25 and p53 to induce cell cycle arrest and repair.
Why is DNA damage checkpoint signaling important in cancer?
Defects in this pathway cause genomic instability and cancer predisposition, while cancer cells often depend on remaining checkpoints for survival.
What are the clinical implications of DNA damage checkpoint kinases?
Checkpoint kinase inhibitors (e.g., CHK1, WEE1, ATM inhibitors) are being tested to sensitize tumors to radiotherapy and chemotherapy.
How can CRISPR be used to study DNA damage checkpoint signaling?
CRISPR knockout, point mutation, knock-in and overexpression models allow functional dissection of checkpoint genes in cell lines.
What methods are used to study DNA damage checkpoint signaling?
Common methods include CRISPR screens, phosphoproteomics, live-cell imaging, RNA-seq, Western blot and flow cytometry.
What diseases are linked to DNA damage checkpoint signaling?
Cancer, neurodegeneration (e.g., ataxia-telangiectasia), premature aging and immune disorders.
What is the role of p53 in DNA damage checkpoint signaling?
p53 is a key effector that induces CDKN1A (p21) to cause G1 arrest and can trigger apoptosis if damage is severe.
How does DNA damage checkpoint signaling connect to immunity?
DNA damage can lead to micronuclei formation, which activates cGAS-STING and innate immune signaling.
Conclusion
DNA damage checkpoint signaling (GO:0000077) is a fundamental biological process that safeguards genomic integrity by coordinating cell cycle arrest and DNA repair. Its dysregulation is central to cancer and other diseases, making it a prime target for therapeutic intervention. Advanced CRISPR models and multi-omics approaches are essential to unravel its complexity and translate findings into clinical benefit.
References
- 1. Huang RX et al.. 2020. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer.. Signal Transduct Target Ther 5(1):60 PMID: 32355263
- 2. Yates LA et al.. 2025. DNA Damage and Replication Stress Checkpoints.. Annu Rev Biochem 94(1):195-221 PMID: 40540755
- 3. Glaviano A et al.. 2025. Cell cycle dysregulation in cancer.. Pharmacol Rev 77(2):100030 PMID: 40148026
- 4. Smith HL et al.. 2020. DNA damage checkpoint kinases in cancer.. Expert Rev Mol Med 22:e2 PMID: 32508294
- 5. Harding SM et al.. 2017. Mitotic progression following DNA damage enables pattern recognition within micronuclei.. Nature 548(7668):466-470 PMID: 28759889
- 6. Regulski MJ. 2017. Cellular Senescence: What, Why, and How.. Wounds 29(6):168-174 PMID: 28682291
- 7. Ha CT et al.. 2024. The entanglement of DNA damage and pattern recognition receptor signaling.. DNA Repair (Amst) 133:103595 PMID: 37988925
- 8. Herbst J et al.. 2024. Mechanistic insights into DNA damage recognition and checkpoint control in plants.. Nat Plants 10(4):539-550 PMID: 38503962
